84.52
Healthequity Inc stock is traded at $84.52, with a volume of 943.97K.
It is up +2.46% in the last 24 hours and down -16.08% over the past month.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
See More
Previous Close:
$82.49
Open:
$82.15
24h Volume:
943.97K
Relative Volume:
0.92
Market Cap:
$7.21B
Revenue:
$1.15B
Net Income/Loss:
$96.70M
P/E Ratio:
77.54
EPS:
1.09
Net Cash Flow:
$-161.99M
1W Performance:
+5.73%
1M Performance:
-16.08%
6M Performance:
-3.95%
1Y Performance:
+5.82%
Healthequity Inc Stock (HQY) Company Profile
Name
Healthequity Inc
Sector
Industry
Phone
801-727-1000
Address
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
HQY
Healthequity Inc
|
84.52 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
VEEV
Veeva Systems Inc
|
215.95 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
53.21 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
40.45 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
WAY
Waystar Holding Corp
|
36.45 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-25-25 | Upgrade | Raymond James | Outperform → Strong Buy |
Dec-04-24 | Initiated | Mizuho | Outperform |
Nov-15-24 | Initiated | Goldman | Neutral |
Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
Apr-02-24 | Reiterated | JP Morgan | Overweight |
Jan-03-24 | Initiated | Barclays | Overweight |
Sep-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Oct-21-22 | Upgrade | Goldman | Sell → Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Jul-12-22 | Initiated | Goldman | Sell |
Apr-11-22 | Initiated | Wells Fargo | Overweight |
Apr-07-22 | Initiated | Guggenheim | Buy |
Mar-30-22 | Upgrade | BTIG Research | Neutral → Buy |
Dec-07-21 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-02-21 | Initiated | Jefferies | Buy |
Sep-09-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Jul-02-21 | Initiated | Stephens | Overweight |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Jan-07-21 | Initiated | BTIG Research | Neutral |
Dec-08-20 | Reiterated | Barrington Research | Outperform |
Dec-02-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Nov-23-20 | Downgrade | Guggenheim | Buy → Neutral |
Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
Apr-14-20 | Initiated | Guggenheim | Buy |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Mar-17-20 | Reiterated | Barrington Research | Outperform |
Oct-07-19 | Initiated | Goldman | Neutral |
Sep-09-19 | Upgrade | Raymond James | Outperform → Strong Buy |
Jul-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jun-05-19 | Reiterated | BofA/Merrill | Neutral |
Mar-01-19 | Reiterated | BofA/Merrill | Neutral |
Feb-07-19 | Reiterated | Chardan Capital Markets | Buy |
Feb-07-19 | Upgrade | SunTrust | Hold → Buy |
Dec-06-18 | Downgrade | SunTrust | Buy → Hold |
Sep-06-18 | Downgrade | BofA/Merrill | Buy → Neutral |
May-23-18 | Initiated | BofA/Merrill | Buy |
Apr-24-18 | Resumed | JP Morgan | Overweight |
Mar-20-18 | Reiterated | Chardan Capital Markets | Buy |
Dec-06-17 | Reiterated | Chardan Capital Markets | Buy |
View All
Healthequity Inc Stock (HQY) Latest News
Zacks Research Reduces Earnings Estimates for HealthEquity - MarketBeat
KeyCorp Cuts HealthEquity (NASDAQ:HQY) Price Target to $100.00 - The AM Reporter
Wells Fargo & Company MN Has $11.99 Million Position in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
Cerity Partners LLC Sells 1,059 Shares of HealthEquity, Inc. (NASDAQ:HQY) - The AM Reporter
HealthEquity, Inc. Announcement: If You Have Suffered - GlobeNewswire
Invesco Ltd. Increases Holdings in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Shares Acquired by Russell Investments Group Ltd. - MarketBeat
Black Men’s Health Equity Conference - WJTV
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATNM - GlobeNewswire Inc.
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ - Bluefield Daily Telegraph
Zacks Research Lowers Earnings Estimates for HealthEquity - MarketBeat
KeyCorp Lowers HealthEquity (NASDAQ:HQY) Price Target to $100.00 - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) is Wasatch Advisors LP's 2nd Largest Position - MarketBeat
Arrowstreet Capital Limited Partnership Lowers Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
Grandeur Peak Global Advisors LLC Has $12.51 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Next Century Growth Investors LLC - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Receives $112.58 Average Price Target from Analysts - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity - Bluefield Daily Telegraph
Why Is HealthEquity (HQY) Down 2.2% Since Last Earnings Report? - Yahoo
Raymond James Financial Inc. Invests $45.73 Million in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
HealthEquity FY2028 EPS Forecast Lowered by Zacks Research - Defense World
Quinn Opportunity Partners LLC Invests $1.29 Million in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
Lobbying Update: $30,000 of HEALTHEQUITY INC. lobbying was just disclosed - Nasdaq
Bessemer Group Inc. Boosts Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity price target lowered to $100 from $110 at KeyBanc - TipRanks
Wells Fargo & Company MN Buys 5,594 Shares of HealthEquity, Inc. (NASDAQ:HQY) - Defense World
HealthEquity (NASDAQ:HQY) Receives Outperform Rating from Barrington Research - MarketBeat
Q1 EPS Estimates for HealthEquity Reduced by Zacks Research - MarketBeat
HealthEquity Stock Plunges 13% YTD: Is It Time to Exit or Hold? - Yahoo Finance
HealthEquity's Expedited Claims Technology Wins Artificial Intel - GuruFocus
HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards - GlobeNewswire
HealthEquity's Game-Changing AI Slashes Claims Processing Time by 70% - Stock Titan
Resona Asset Management Co. Ltd. Invests $1.51 Million in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
Fmr LLC Increases Stock Position in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by LPL Financial LLC - MarketBeat
Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action InvestigationHQY - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc.HQY - PR Newswire
Alliancebernstein L.P. Sells 4,290 Shares of HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
Ranger Investment Management L.P. Acquires 45,130 Shares of HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) EVP Sells $695,027.06 in Stock - MarketBeat
HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Arrowstreet Capital Limited Partnership - Defense World
Renaissance Group LLC Increases Stake in HealthEquity, Inc. (NASDAQ:HQY) - MarketBeat
HealthEquity (NASDAQ:HQY) Earns Outperform Rating from Barrington Research - Defense World
HealthEquity, Inc. Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights - TradingView
Healthequity Inc Stock (HQY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Healthequity Inc Stock (HQY) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SELANDER ROBERT W | Director |
Apr 09 '25 |
Sale |
77.65 |
5,750 |
446,513 |
84,969 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):